Publicaciones en las que colabora con José David Machado Ponce (17)

2021

  1. Differences in Capacity of High-Density Lipoprotein Cholesterol Efflux Between Patients With Systemic Lupus Erythematosus and Rheumatoid Arthritis

    Arthritis Care and Research, Vol. 73, Núm. 11, pp. 1590-1596

  2. HDL cholesterol efflux capacity and lipid profile in patients with systemic sclerosis

    Arthritis Research and Therapy, Vol. 23, Núm. 1

2020

  1. HDL cholesterol efflux capacity is related to disease activity in psoriatic arthritis patients

    Clinical Rheumatology, Vol. 39, Núm. 6, pp. 1871-1880

  2. Impaired HDL cholesterol efflux capacity in systemic lupus erythematosus patients is related to subclinical carotid atherosclerosis

    Rheumatology (Oxford, England), Vol. 59, Núm. 10, pp. 2847-2856

2019

  1. Effect of IL-6 Receptor Blockade on Proprotein Convertase Subtilisin/Kexin Type-9 and Cholesterol Efflux Capacity in Rheumatoid Arthritis Patients

    Hormone and Metabolic Research, Vol. 51, Núm. 3, pp. 200-209

2017

  1. Functional effects of proinflammatory factors present in Sjogren's syndrome salivary microenvironment in an in vitro model of human salivary gland

    Scientific Reports, Vol. 7, Núm. 1

  2. HDL cholesterol efflux capacity in rheumatoid arthritis patients: Contributing factors and relationship with subclinical atherosclerosis

    Arthritis Research and Therapy, Vol. 19, Núm. 1

2014

  1. Prevention of neutrophil extravasation by α2-Adrenoceptor-mediated endothelial stabilization

    Journal of Immunology, Vol. 193, Núm. 6, pp. 3023-3035

2012

  1. Chromogranins A and B are key proteins in amine accumulation, but the catecholamine secretory pathway is conserved without them

    FASEB Journal, Vol. 26, Núm. 1, pp. 430-438

2010

  1. Chromogranin B gene ablation reduces the catecholamine cargo and decelerates exocytosis in chromaffin secretory vesicles

    Journal of Neuroscience, Vol. 30, Núm. 3, pp. 950-957

2008

  1. The crucial role of chromogranins in storage and exocytosis revealed using chromaffin cells from chromogranin A null mouse

    Journal of Neuroscience, Vol. 28, Núm. 13, pp. 3350-3358

2002

  1. Hydralazine reduces the quantal size of secretory events by displacement of catecholamines from adrenomedullary chromaffin secretory vesicles

    Circulation Research, Vol. 91, Núm. 9, pp. 830-836

  2. New approaches for analysis of amperometrical recordings

    Annals of the New York Academy of Sciences

  3. Nongenomic regulation of the kinetics of exocytosis by estrogens

    Journal of Pharmacology and Experimental Therapeutics, Vol. 301, Núm. 2, pp. 631-637

2001

  1. cAMP modulates exocytotic kinetics and increases quantal size in chromaffin cells

    Molecular Pharmacology, Vol. 60, Núm. 3, pp. 514-520

2000

  1. Automatic analysis for amperometrical recordings of exocytosis

    Journal of Neuroscience Methods, Vol. 103, Núm. 2, pp. 151-156

  2. Functional role of chromogranins: The intragranular matrix in the last phase of exocytosis

    Advances in Experimental Medicine and Biology